Opinion
Video
Focusing on elacestrant, Dr Graff discusses the role of oral SERDs (selective estrogen receptor degraders) in the treatment of patients with ER+/HER2- metastatic breast cancer.
Meta-Analysis Finds Link Between Ankylosing Spondylitis, Cancer Risk
Insurance Insights: Dr Jason Shafrin Estimates DMD Insurance Value
ARTISTRY-1: Simplifying HIV Treatment for the Most Complex Cases
From Polypharmacy to Personalized Care: Dr Nihar Desai Discusses Holistic Cardiovascular Care
Atezolizumab for NSCLC Safe and Effective Before and After CRT
Dual-Target CAR T Cells Achieve 100% Response Rate in MM